[Federal Register Volume 79, Number 164 (Monday, August 25, 2014)]
[Notices]
[Pages 50653-50654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-20101]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-14AUI]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below proposed project or to obtain a copy of the information
collection plan and instruments, call 404-639-7570 or send comments to
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or
send an email to [email protected].
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
WISEWOMAN National Program Evaluation--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the WISEWOMAN program (Well-Integrated
Screening and Evaluation for Women Across the Nation) since 1995. The
WISEWOMAN program is designed to serve low-income women ages 40-64 who
have elevated risk factors for cardiovascular disease (CVD) and have no
health insurance, or are underinsured for medical and preventive care
services. Through the WISEWOMAN program, women have access to screening
services for selected CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal blood glucose levels; referrals
to lifestyle programs; and referrals to medical care. WISEWOMAN
participants must be co-enrolled in the CDC-sponsored National Breast
and Cervical Cancer Early Detection Program (NBCCEDP).
The WISEWOMAN program is administered through cooperative
agreements with state, territorial, or tribal health departments. At
present, approximately two-thirds of program funding is provided by CDC
with the other one-third supplied by the state, territory, or tribal
organization. Each WISEWOMAN awardee submits to CDC an annual progress
report that describes program objectives and activities, and semi-
annual data reports (known as minimum data elements, or MDE) on the
screening, assessment, and lifestyle program services offered to women
who participate in the program (see WISEWOMAN Reporting System, OMB No.
0920-0612, exp. 12/31/2016). Participant-level MDE are de-identified
prior to transmission to CDC.
In 2013, CDC released the fourth funding opportunity announcement
(FOA) for the WISEWOMAN program (DP13-1302), which resulted in four-
year cooperative agreements with 22 state, territorial, and tribal
health departments, including 5 new and 17 continuing awardees from the
previous FOA. Key program elements were retained (e.g., provision of
screening services, promotion of healthy lifestyle behaviors, and
linkage to community resources), but a number of changes were
incorporated into the program at that time due to shifts in
populations, systems, and community needs. The current FOA reflects
increased emphasis on improving access to clinical systems of care and
increased emphasis on
[[Page 50654]]
leveraging existing resources in the community. Lifestyle interventions
have also been reframed to include lifestyle programs (LSPs) and health
coaching (HC) sessions, and MDE have been updated to capture
information about risk reduction counseling and participants' readiness
to change. The current cooperative agreement also stresses monitoring
and performance evaluation as key program dimensions. Additionally,
more information is needed to augment that from previous evaluation
efforts.
CDC seeks to conduct a one-time, multi-component evaluation to
assess the effectiveness of the program on individual-, organizational-
, and community-level outcomes. The in-depth assessment is designed to
complement the routine progress and MDE information already being
collected from WISEWOMAN program awardees. The new data collection will
focus on obtaining qualitative and quantitative information at the
organizational and community levels about process and procedures
implemented, and barriers, facilitators, and other contextual factors
that affect program implementation and participant outcomes. Data
collection activities will include a Program Survey with all WISEWOMAN
awardee programs, administered in the second and fourth program years;
a Network Survey of WISEWOMAN awardees and partner organizations, also
conducted in the second and fourth program years; and a one-time Site
Visit to a subset of awardees across the second to fourth program
years. During site visits, semi-structured interviews will be conducted
with WISEWOMAN staff members who serve in diverse roles and are
positioned to provide a variety of perspectives on program
implementation.
OMB approval is requested for three years. Participation is
voluntary and there are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Awardee Program Survey.. 15 1 70/60 18
Administrators.
Network Survey.. 15 1 50/60 13
Site Visit 6 1 75/60 8
Interview Guide.
Awardee Partners.............. Network Survey.. 147 1 50/60 123
Site Visit 12 1 45/60 9
Interview Guide.
Healthy Behavior Support staff Site Visit 12 1 45/60 9
Interview Guide.
Clinical Providers............ Site Visit 12 1 45/60 9
Interview Guide.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 189
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-20101 Filed 8-22-14; 8:45 am]
BILLING CODE 4163-18-P